Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventionsAngeliki Zarkali(UK Dementia Research Institute), Rimona S. Weil(University College London)Nature CommunicationsJuly 5, 202410.1038/s41467-024-49949-9Cited by 87SaveCiteExport RISWatch citationsRelated PapersRetinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease|Neurology|2023|86